gabapentin teva 300 mg
teva israel ltd - gabapentin - capsules - gabapentin 300 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
gabapentin teva 300 mg
teva pharmaceutical industries ltd, israel - gabapentin - capsules - gabapentin 300 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
gabapentin teva 400 mg
teva israel ltd - gabapentin - capsules - gabapentin 400 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
gabapentin teva 400 mg
teva pharmaceutical industries ltd, israel - gabapentin - capsules - gabapentin 400 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
gabapentin teva 600 mg
teva pharmaceutical industries ltd, israel - gabapentin - tablets - gabapentin 600 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
gabapentin teva 800 mg
teva pharmaceutical industries ltd, israel - gabapentin - tablets - gabapentin 800 mg - gabapentin - gabapentin - epilepsy :- gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents ( age 12 and up ) with epilepsy.- treatment of neuropathic pain- gabapentin is indicated for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy(neuralgia) in adults.
maxibone 10
unipharm ltd, israel - alendronic acid as sodium - tablets - alendronic acid as sodium 10 mg - alendronic acid - alendronic acid - treatment of osteoporosis in postmenopausal women: maxibone is indicated for the treatment of osteoporosis to prevent fractures, including those of the hip, wrist and spine ( vertebral compression fractures). prevention and treatment of glucocorticoid-induced osteoporosis: maxibone is indicated for the prevention and treatment of glucocorticoid-induced osteoporosis in men and women. for the treatment of osteoporosis in men.
adempas 0.5mg
bayer israel ltd - riociguat - film coated tablets - riociguat 0.5 mg - riociguat - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii with • inoperable cteph, • persistent or recurrent cteph after surgical treatment, to improve exercise capacity. pulmonary arterial hypertension (pah)adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity.efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.
adempas 0.5 mg
bayer israel ltd - riociguat - film coated tablets - riociguat 0.5 mg - riociguat - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii with • inoperable cteph, • persistent or recurrent cteph after surgical treatment, to improve exercise capacity. pulmonary arterial hypertension (pah)adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity.efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.
adempas 1 mg
bayer israel ltd - riociguat - film coated tablets - riociguat 1 mg - riociguat - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii with • inoperable cteph, • persistent or recurrent cteph after surgical treatment, to improve exercise capacity. pulmonary arterial hypertension (pah)adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity.efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.